Variant report

Variant	nsv893425
Chromosome Location	chr9:71627754-71642499
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:230)
CpG islands
(count:183)
Chromatin interactive
region (count:17)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:230 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:71631852-71631872	K562	blood:	n/a	n/a
2	ARID3A	chr9:71634748-71635103	K562	blood:	n/a	n/a
3	ARID3A	chr9:71635426-71635919	K562	blood:	n/a	n/a
4	ATF1	chr9:71634756-71635094	K562	blood:	n/a	n/a
5	ATF1	chr9:71635543-71635967	K562	blood:	n/a	n/a
6	BACH1	chr9:71634639-71634975	K562	blood:	n/a	n/a
7	BHLHE40	chr9:71633440-71634093	K562	blood:	n/a	n/a
8	BHLHE40	chr9:71634550-71635063	K562	blood:	n/a	n/a
9	BHLHE40	chr9:71631696-71631742	K562	blood:	n/a	n/a
10	CBX3	chr9:71634637-71635116	K562	blood:	n/a	n/a
11	CBX3	chr9:71634767-71635088	K562	blood:	n/a	n/a
12	CCNT2	chr9:71634748-71635750	K562	blood:	n/a	n/a
13	CEBPB	chr9:71634690-71635114	K562	blood:	n/a	n/a
14	CEBPB	chr9:71634509-71635001	K562	blood:	n/a	n/a
15	CEBPD	chr9:71634734-71635203	K562	blood:	n/a	n/a
16	CEBPD	chr9:71634663-71635222	K562	blood:	n/a	n/a
17	CHD2	chr9:71634776-71635089	K562	blood:	n/a	n/a
18	CTCF	chr9:71638240-71638390	Hela-S3	cervix:	n/a	n/a
19	CTCF	chr9:71642200-71642350	GM12874	blood:	n/a	n/a
20	CTCF	chr9:71642480-71642911	A549	lung:	n/a	n/a
21	CTCF	chr9:71642260-71642410	HBMEC	blood vessel:	n/a	n/a
22	CTCF	chr9:71642220-71642370	GM12864	blood:	n/a	n/a
23	CTCF	chr9:71628120-71628170	GM13976	blood:	n/a	n/a
24	CTCF	chr9:71628173-71628180	GM13976	blood:	n/a	n/a
25	CTCF	chr9:71633900-71634050	GM12873	blood:	n/a	n/a
26	CTCF	chr9:71627804-71627970	GM19240	blood:	n/a	n/a
27	CTCF	chr9:71633783-71633862	MCF-7	breast:	n/a	n/a
28	CTCF	chr9:71633760-71633910	GM12865	blood:	n/a	n/a
29	CTCF	chr9:71642100-71642250	GM12870	blood:	n/a	n/a
30	CTCF	chr9:71633675-71633960	GM12878	blood:	n/a	n/a
31	CTCF	chr9:71642310-71643197	SK-N-SH	brain:	n/a	n/a
32	CTCF	chr9:71642454-71642997	MCF-7	breast:	n/a	n/a
33	CTCF	chr9:71633720-71633870	GM12868	blood:	n/a	n/a
34	CTCF	chr9:71633670-71633989	K562	blood:	n/a	n/a
35	CTCF	chr9:71629142-71629173	H1-hESC	embryonic stem cell:	n/a	n/a
36	CTCF	chr9:71642478-71642933	GM12878	blood:	n/a	n/a
37	CTCF	chr9:71627900-71628050	GM12873	blood:	n/a	n/a
38	CTCF	chr9:71642080-71642230	GM12864	blood:	n/a	n/a
39	CTCF	chr9:71633740-71633890	GM12875	blood:	n/a	n/a
40	CTCF	chr9:71642020-71642170	BJ	skin:	n/a	n/a
41	CTCF	chr9:71633760-71633910	GM12864	blood:	n/a	n/a
42	CTCF	chr9:71633720-71633870	GM06990	blood:	n/a	n/a
43	CTCF	chr9:71633760-71633910	GM12872	blood:	n/a	n/a
44	CTCF	chr9:71642280-71642430	HEK293	kidney:	n/a	n/a
45	CTCF	chr9:71633760-71633910	GM12873	blood:	n/a	n/a
46	CTCF	chr9:71629112-71629136	H1-hESC	embryonic stem cell:	n/a	n/a
47	CTCF	chr9:71642296-71643177	A549	lung:	n/a	n/a
48	CTCF	chr9:71641020-71641170	SK-N-SH_RA	brain:	n/a	n/a
49	CTCF	chr9:71627811-71627880	GM19239	blood:	n/a	n/a
50	CTCF	chr9:71642140-71642290	HMEC	breast:	n/a	n/a

(count:183 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:71629130-71629180	HCT-116	colon:	n/a
2	chr9:71631514-71631564	SK-N-SH_RA	brain:	n/a
3	chr9:71629130-71629180	BJ	skin:	n/a
4	chr9:71629130-71629180	SKMC	muscle:	n/a
5	chr9:71629130-71629180	ovcar-3	ovarian:	n/a
6	chr9:71631514-71631564	BJ	skin:	n/a
7	chr9:71629130-71629180	T-47D	breast:	n/a
8	chr9:71629130-71629180	AG09309	skin:	n/a
9	chr9:71628906-71628956	HRCEpiC	kidney:	n/a
10	chr9:71628906-71628956	AG04449	skin:	fetal
11	chr9:71629130-71629180	GM12891	blood:	n/a
12	chr9:71629130-71629180	A549	lung:	n/a
13	chr9:71629130-71629180	AG10803	skin:	n/a
14	chr9:71629130-71629180	HPAEpiC	pulmonary alveolar:	n/a
15	chr9:71631514-71631564	HCT-116	colon:	n/a
16	chr9:71631514-71631564	Hela-S3	cervix:	n/a
17	chr9:71629130-71629180	AG04450	lung:	fetal
18	chr9:71629130-71629180	SAEC	small airway:	n/a
19	chr9:71629130-71629180	PANC-1	pancreas:	n/a
20	chr9:71628906-71628956	SK-N-SH	brain:	n/a
21	chr9:71631514-71631564	IMR90	lung:	fetal
22	chr9:71629130-71629180	HAEpiC	amniotic membrane:	n/a
23	chr9:71631514-71631564	AG09319	gingival:	n/a
24	chr9:71631514-71631564	SAEC	small airway:	n/a
25	chr9:71629130-71629180	HCF	heart:	n/a
26	chr9:71628906-71628956	SAEC	small airway:	n/a
27	chr9:71631514-71631564	CMK	blood:	n/a
28	chr9:71631514-71631564	HCPEpiC	choroid plexus:	n/a
29	chr9:71628906-71628956	HPAEpiC	pulmonary alveolar:	n/a
30	chr9:71628906-71628956	PFSK-1	brain:	n/a
31	chr9:71628906-71628956	H1-hESC	embryonic stem cell:	embryo
32	chr9:71628906-71628956	T-47D	breast:	n/a
33	chr9:71629130-71629180	SK-N-SH	brain:	n/a
34	chr9:71629130-71629180	HCPEpiC	choroid plexus:	n/a
35	chr9:71628906-71628956	HIPEpiC	eye:	n/a
36	chr9:71628906-71628956	ProgFib	skin:	n/a
37	chr9:71631514-71631564	HPAEpiC	pulmonary alveolar:	n/a
38	chr9:71631514-71631564	AG04450	lung:	fetal
39	chr9:71628906-71628956	HEEpiC	esophagus:	n/a
40	chr9:71631514-71631564	AG10803	skin:	n/a
41	chr9:71628906-71628956	NB4	blood:	n/a
42	chr9:71629130-71629180	AoSMC	blood vessel:	n/a
43	chr9:71628906-71628956	GM12892	blood:	n/a
44	chr9:71629130-71629180	HRCEpiC	kidney:	n/a
45	chr9:71628906-71628956	LNCaP	prostate:	n/a
46	chr9:71629130-71629180	HUVEC	blood vessel:	n/a
47	chr9:71628906-71628956	AG09319	gingival:	n/a
48	chr9:71628906-71628956	HAEpiC	amniotic membrane:	n/a
49	chr9:71631514-71631564	RPTEC	kidney:	n/a
50	chr9:71628906-71628956	SK-N-SH_RA	brain:	n/a

(count:17 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr9:71642182..71645609-chr9:71649881..71653003,5	K562	blood:
2	chr9:71627843..71630592-chr9:71632071..71633725,3	K562	blood:
3	chr9:71634014..71636921-chr9:71638059..71641027,2	K562	blood:
4	chr9:71621939..71625091-chr9:71631557..71634181,3	K562	blood:
5	chr9:71640222..71642541-chr9:71649127..71652222,3	MCF-7	breast:
6	chr9:71628740..71631389-chr9:71634679..71636239,2	K562	blood:
7	chr9:71639276..71640998-chr9:71649555..71652246,2	MCF-7	breast:
8	chr9:71642108..71644566-chr9:71646491..71648725,2	K562	blood:
9	chr9:71637586..71639711-chr9:71650641..71653127,2	K562	blood:
10	chr9:71199108..71199619-chr9:71642191..71643182,2	K562	blood:
11	chr9:71199440..71199949-chr9:71642261..71643160,3	MCF-7	breast:
12	chr9:71459672..71460600-chr9:71642433..71642935,2	K562	blood:
13	chr9:71634014..71636230-chr9:71638337..71641027,2	K562	blood:
14	chr9:71634014..71636230-chr9:71638337..71641027,2	K562	blood:
15	chr9:71634711..71636591-chr9:71649540..71651584,2	MCF-7	breast:
16	chr9:71642300..71643929-chr9:71644528..71647295,2	MCF-7	breast:
17	chr9:71634014..71636921-chr9:71638059..71641027,2	K562	blood:

No data

Variant related genes	Relation type
PRKACG	TF binding region
PRKACG	CpG island
ENSG00000165060	chromatin interactions
ENSG00000165059	chromatin interactions

Extended variants
information (count: 538 )
Associated
traits (count: 58 )

Variant overlapped rSNPs/rCNVs (count:538 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs111390942	chr9:71627754-71627755	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs373006197	chr9:71627755-71627756	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs3812538	chr9:71627756-71627757	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs41296340	chr9:71627757-71627758	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs566948575	chr9:71627758-71627759	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs3841198	chr9:71627760-71627761	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs201015330	chr9:71627761-71627762	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs554378612	chr9:71627851-71627852	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs572159674	chr9:71627871-71627872	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs367806203	chr9:71627946-71627947	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs149375246	chr9:71627968-71627969	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs17853947	chr9:71627976-71627977	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs536102786	chr9:71628025-71628026	Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs199894106	chr9:71628033-71628034	Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs536396229	chr9:71628036-71628037	Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs146321213	chr9:71628038-71628039	Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs41296338	chr9:71628079-71628080	Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs112974235	chr9:71628083-71628084	Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs543424754	chr9:71628086-71628087	Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs201750972	chr9:71628089-71628090	Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs375696403	chr9:71628091-71628092	Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs375307367	chr9:71628115-71628116	Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs146127115	chr9:71628122-71628123	Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs577099166	chr9:71628126-71628127	Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs555917589	chr9:71628127-71628128	Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs369389606	chr9:71628153-71628154	Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs372968774	chr9:71628163-71628164	Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs148792477	chr9:71628199-71628200	Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs3730386	chr9:71628207-71628208	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs376888405	chr9:71628212-71628213	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs202063130	chr9:71628213-71628214	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs371411361	chr9:71628250-71628251	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs56287972	chr9:71628257-71628258	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs41288749	chr9:71628286-71628287	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs140133619	chr9:71628289-71628290	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs11792214	chr9:71628292-71628293	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs201442995	chr9:71628319-71628320	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs12346259	chr9:71628375-71628376	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs145037702	chr9:71628411-71628412	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs373257940	chr9:71628435-71628436	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs187857817	chr9:71628454-71628455	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs3750373	chr9:71628457-71628458	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs377692902	chr9:71628458-71628459	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs149213270	chr9:71628476-71628477	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs532880421	chr9:71628498-71628499	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs372714447	chr9:71628508-71628509	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs371210848	chr9:71628546-71628547	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs375603378	chr9:71628548-71628549	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs200817879	chr9:71628556-71628557	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs147576281	chr9:71628560-71628561	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:58)

Disease	PMID	Source
Breast cancer	17133270	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Medulloblastoma	21979893	CNVD
microdeletion syndrome	16199537	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
Urothelial carcinoma	21177765	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Melanoma	22183965	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Myelofibrosis	22110671	CNVD
lymphocytic leukemia	21291569	CNVD
Leukemia	17361228	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Glioblastoma	16823260	CNVD
Leukemia	18688285	CNVD
Non-small cell lung cancer	21044232	CNVD
Brain cancer	20823417	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Renal cell carcinoma	19461508	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Heart disease	21282601	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	17899364	CNVD
Mantle cell lymphoma	19029149	CNVD
Hepatocellular carcinoma	16750200	CNVD
Acute myeloid leukemia	20729466	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Oral cancer	21386901	CNVD
Epilepsy	22083797	CNVD
Glioblastoma multiforme	21750150	CNVD
Cancer	21183584	CNVD
Bipolar disorder	18458673	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:266 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:71594800-71628400	Weak transcription	Spleen	Spleen
2	chr9:71595200-71628000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr9:71595200-71631600	Weak transcription	Gastric	stomach
4	chr9:71598800-71644600	Weak transcription	Right Atrium	heart
5	chr9:71607400-71630600	Weak transcription	Aorta	Aorta
6	chr9:71607600-71628000	Weak transcription	Lung	lung
7	chr9:71614600-71630800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr9:71619000-71631200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
9	chr9:71619600-71627800	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
10	chr9:71619600-71631600	Weak transcription	Left Ventricle	heart
11	chr9:71622200-71634600	Weak transcription	Fetal Heart	heart
12	chr9:71623400-71631600	Weak transcription	Pancreas	Pancrea
13	chr9:71624600-71628000	Weak transcription	Fetal Intestine Small	intestine
14	chr9:71624600-71630600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
15	chr9:71625000-71628000	Weak transcription	Fetal Intestine Large	intestine
16	chr9:71625000-71628200	Weak transcription	Rectal Mucosa Donor 29	rectum
17	chr9:71625000-71634600	Weak transcription	Duodenum Mucosa	Duodenum
18	chr9:71625400-71628000	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
19	chr9:71626800-71628400	Enhancers	Primary hematopoietic stem cells	blood
20	chr9:71627000-71627800	Enhancers	iPS-20b Cell Line	embryonic stem cell
21	chr9:71627000-71627800	Enhancers	Primary monocytes fromperipheralblood	blood
22	chr9:71627000-71628000	Enhancers	Primary hematopoietic stem cells short term culture	blood
23	chr9:71627000-71628400	Enhancers	Primary B cells from cord blood	blood
24	chr9:71627000-71628400	Enhancers	Primary B cells from peripheral blood	blood
25	chr9:71627400-71627800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
26	chr9:71627400-71627800	Enhancers	GM12878-XiMat	blood
27	chr9:71627400-71627800	Enhancers	Monocytes-CD14+_RO01746	blood
28	chr9:71627400-71628000	Enhancers	Dnd41	blood
29	chr9:71627600-71627800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
30	chr9:71627600-71628200	Enhancers	Primary T helper naive cells fromperipheralblood	blood
31	chr9:71627600-71628200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
32	chr9:71627600-71628200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
33	chr9:71627600-71628400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
34	chr9:71627600-71628400	Enhancers	Primary T helper naive cells from peripheral blood	blood
35	chr9:71627600-71628400	Enhancers	Primary T helper cells PMA-I stimulated	--
36	chr9:71627600-71628400	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
37	chr9:71627600-71628400	Enhancers	Primary T regulatory cells fromperipheralblood	blood
38	chr9:71627600-71628600	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
39	chr9:71627600-71628600	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
40	chr9:71627800-71628000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
41	chr9:71627800-71628000	Flanking Active TSS	GM12878-XiMat	blood
42	chr9:71627800-71628200	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
43	chr9:71627800-71628200	Enhancers	Primary T helper cells fromperipheralblood	blood
44	chr9:71627800-71628200	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
45	chr9:71627800-71628400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
46	chr9:71627800-71630600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
47	chr9:71627800-71632200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
48	chr9:71628000-71628200	Bivalent Enhancer	Primary T cells from cord blood	blood
49	chr9:71628000-71628200	Enhancers	GM12878-XiMat	blood
50	chr9:71628000-71628400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links